Reintervention for arch obstruction after stage 1 reconstruction does not adversely affect survival or outcome at Fontan completion

J Thorac Cardiovasc Surg. 2010 Sep;140(3):545-9. doi: 10.1016/j.jtcvs.2010.06.013.

Abstract

Objective: To determine the effect of reintervention for coarctation after stage 1 reconstruction for hypoplastic left heart syndrome and variants on survival, suitability for Fontan, and morbidity at Fontan.

Methods: A retrospective review of echocardiograms, catheterizations, hospital records of patients who underwent stage 1 reconstruction from January 2002 to May 2005, with a cross-sectional analysis of hospital survivors, was performed. Kaplan-Meier curves were derived for patients alive more than 30 days after stage 1 reconstruction.

Results: A total of 176 patients underwent stage 1 reconstruction. Forty-three patients (23%) underwent balloon angioplasty (n = 43) or surgical intervention (n = 4) for re-coarctation. Median time to intervention was 123 (1-316) days. Seven of 43 patients (16%) underwent more than 1 balloon angioplasty. Thirty-nine patients underwent intervention before stage 2 reconstruction, and 4 patients had intervention between stage 2 reconstruction and Fontan. Kaplan-Meier curves showed no difference in freedom from death or transplant between patients who did and did not undergo intervention for re-coarctation. Fontan completion was performed in 107 patients. By echocardiogram, the prevalence of moderate to severe ventricular dysfunction between groups was similar at Fontan; however, significant atrioventricular valve regurgitation was more common in patients who required intervention (28/33 vs 40/65, P = .02). Overall Fontan mortality was 2% and not different between groups. Length of stay was not different between patients with and without re-coarctation.

Conclusions: Reintervention for coarctation after stage 1 reconstruction is common. Hemodynamic differences between groups did not affect Fontan completion, mortality, or hospital length of stay. Follow-up is necessary to determine the impact of re-coarctation on longer-term mortality and morbidity.

MeSH terms

  • Angioplasty, Balloon* / adverse effects
  • Angioplasty, Balloon* / mortality
  • Aortic Coarctation / complications
  • Aortic Coarctation / diagnosis
  • Aortic Coarctation / mortality
  • Aortic Coarctation / physiopathology
  • Aortic Coarctation / surgery
  • Aortic Coarctation / therapy*
  • Cardiac Catheterization
  • Cross-Sectional Studies
  • Echocardiography
  • Fontan Procedure* / adverse effects
  • Fontan Procedure* / mortality
  • Heart Valve Diseases / etiology
  • Heart Valve Diseases / surgery
  • Hemodynamics
  • Humans
  • Hypoplastic Left Heart Syndrome / complications
  • Hypoplastic Left Heart Syndrome / diagnosis
  • Hypoplastic Left Heart Syndrome / mortality
  • Hypoplastic Left Heart Syndrome / physiopathology
  • Hypoplastic Left Heart Syndrome / surgery*
  • Kaplan-Meier Estimate
  • Length of Stay
  • Philadelphia
  • Proportional Hazards Models
  • Recurrence
  • Reoperation
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Vascular Surgical Procedures* / adverse effects
  • Vascular Surgical Procedures* / mortality
  • Ventricular Dysfunction / etiology
  • Ventricular Dysfunction / surgery